Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.6B | 11.5B | 11.4B | 7.7B |
Cost of revenue | 12.2B | 8.8B | 8.9B | 5.5B |
Gross profit | 5.4B | 2.7B | 2.5B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | 645.1M | 804.2M | 644.1M |
Operating income | 2.4B | 2.1B | 1.7B | 1.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 117.6M | 108.5M | 93.6M | 66.1M |
Other income expense | — | — | — | — |
Pretax income | 3.8B | 2.4B | 2.6B | 2.4B |
Tax provision | 968.8M | 648.7M | 745.0M | 615.9M |
Net income | 2.9B | 1.8B | 1.9B | 1.7B |
Basic EPS | — | 6.7 | 7.2 | 6.6 |
Diluted EPS | — | 6.7 | 7.2 | 6.6 |
Basic average shares | — | 263.0M | 263.1M | 263.2M |
Diluted average shares | — | 263.0M | 263.1M | 263.2M |
EBITDA | 4.0B | 2.5B | 2.7B | 2.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |